H6U logo

CapsoVision, Inc.DB:H6U Stock Report

Market Cap €291.4m
Share Price
€5.50
€8.28
33.6% undervalued intrinsic discount
1Yn/a
7D1.9%
1D
Portfolio Value
View

CapsoVision, Inc.

DB:H6U Stock Report

Market Cap: €291.4m

CapsoVision (H6U) Stock Overview

A medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. More details

H6U fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

H6U Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

CapsoVision, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for CapsoVision
Historical stock prices
Current Share PriceUS$5.50
52 Week HighUS$12.85
52 Week LowUS$3.70
Beta0
1 Month Change20.09%
3 Month Change47.06%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO9.06%

Recent News & Updates

Recent updates

Shareholder Returns

H6UDE Medical EquipmentDE Market
7D1.9%2.6%3.2%
1Yn/a-27.3%2.5%

Return vs Industry: Insufficient data to determine how H6U performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how H6U performed against the German Market.

Price Volatility

Is H6U's price volatile compared to industry and market?
H6U volatility
H6U Average Weekly Movement22.8%
Medical Equipment Industry Average Movement6.1%
Market Average Movement6.1%
10% most volatile stocks in DE Market13.6%
10% least volatile stocks in DE Market2.7%

Stable Share Price: H6U's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine H6U's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200599Johnny Wangcapsovision.com

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services.

CapsoVision, Inc. Fundamentals Summary

How do CapsoVision's earnings and revenue compare to its market cap?
H6U fundamental statistics
Market cap€291.44m
Earnings (TTM)-€23.24m
Revenue (TTM)€11.69m
24.5x
P/S Ratio
-12.3x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
H6U income statement (TTM)
RevenueUS$13.56m
Cost of RevenueUS$6.56m
Gross ProfitUS$7.01m
Other ExpensesUS$33.98m
Earnings-US$26.97m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.54
Gross Margin51.67%
Net Profit Margin-198.87%
Debt/Equity Ratio0%

How did H6U perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/22 14:00
End of Day Share Price 2026/05/22 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CapsoVision, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bruce JacksonBenchmark Company
Jason WittesRoth Capital Partners
Kyle BauserRoth Capital Partners